Recent ZNTL News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2025 10:17:05 PM
- Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 01/02/2025 09:53:30 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/19/2024 09:01:43 PM
- Zentalis Pharmaceuticals Announces Key Management Appointments • GlobeNewswire Inc. • 12/12/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2024 12:02:41 AM
- Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 12/02/2024 09:35:10 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2024 10:46:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2024 01:06:01 PM
- Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of Azenosertib • GlobeNewswire Inc. • 11/13/2024 01:00:00 PM
- Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 11/01/2024 11:04:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 10:01:21 PM
- Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm • PR Newswire (US) • 09/17/2024 01:38:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 11:02:19 AM
- Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies • GlobeNewswire Inc. • 09/16/2024 11:00:00 AM
- Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024 • GlobeNewswire Inc. • 09/09/2024 11:00:00 AM
- Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/03/2024 08:40:50 PM
- Newman Ferrara LLP Announces Corporate Governance Investigation of Zentalis Pharmaceuticals, Inc. – ZNTL • Business Wire • 08/19/2024 08:55:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 11:03:55 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 11:01:42 AM
- Zentalis Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Progress • GlobeNewswire Inc. • 08/09/2024 11:00:00 AM
- Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/01/2024 10:00:00 PM
- Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm • PR Newswire (US) • 07/25/2024 06:49:00 PM
- Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/01/2024 10:00:47 PM
- Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program • GlobeNewswire Inc. • 06/18/2024 11:00:00 AM
- Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/03/2024 10:00:55 PM
Fifty 1 Labs, Inc. Launches Dedicated Website for Shareholders and Investors, Company now current with OTC Markets • CAFI • Jan 7, 2025 9:00 AM
EzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion • EZFL • Jan 7, 2025 8:35 AM
CGRA Signs Binding Term Sheet to Merge With American Infrastructure Corporation, a Subsidiary of Nasdaq-listed American Resources Corporation (Nasdaq: AREC) • CGRA • Jan 6, 2025 10:31 AM
UAV Corp (UMAV) Working on Securing $1.5 Billion in Contracts and Announces Groundbreaking Partnership with Atlantic Industrial Group • UMAV • Jan 6, 2025 9:26 AM
Basanite, Inc. to Open New Production and Distribution Facility in Northeast Ohio • BASA • Jan 2, 2025 8:28 AM
The Crypto Company Highlights Blockchain Training Alliance's Successes and Momentum for 2025 • CRCW • Dec 26, 2024 8:58 AM